Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT02159469
Brief Summary:
Evaluation of efficacy and safety of testosterone enanthate administered subcutaneously using an auto-injector
Detailed Description:
This study will evaluate, if testosterone enanthate administered subcutaneously once each week by an auto-injector to men with low testosterone, can raise their levels into the normal range.
The study will investigate the ability to adjust testosterone enanthate dose levels using single point blood concentrations.
Safety and tolerability of testosterone administration will be evaluated along with the patient's ability to use the auto-injector and follow the instructions for auto-injector use.
Study:
NCT02159469
Study Brief:
Protocol Section:
NCT02159469